Logo Made in Germany BIO 2017

The Medigene Investment Case

  • Medigene’s immunotherapy programs are deeply rooted in world-class science
  • Established company for biopharmaceutical product development from research to market approval
  • Management team composed of Medigene’s immunotherapies inventors in addition to very experienced executives from the biopharmaceutical industry
  • Up-scalable technology platforms for fueling continual development of candidates for the pipeline – for Medigene and Partners
  • Unique knowledge and speed on TCR discovery and validation
  • Well funded

Exhibitor: Medigene AG

Your personal organizer

Your personal organizer

Print list  |  Save as PDF
Xell AG
Booth number: